Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June

Cancer Genetics Risk Assessment and Counseling (PDQ®) - PDQ Cancer Information Summaries - NCBI Bookshelf

Frontiers Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection

Biomarker discovery process at binomial decision point (2BDP): Analytical pipeline to construct biomarker panel - Computational and Structural Biotechnology Journal

Gene-Panel Sequencing and the Prediction of Breast-Cancer Risk

Pie-chart showing the percentage of mutations across the 25 genes.

Gene panel screening for insight towards breast cancer susceptibility in different ethnicities

Cureus Genetic Variation and the Role of Multigene Panel Testing for Hereditary Breast Cancer: A Single-Institution Experience

A novel prognostic two-gene signature for triple negative breast cancer - Modern Pathology

Combining rare and common genetic variants improves population risk stratification for breast cancer

Frontiers Double heterozygous pathogenic variants prevalence in a cohort of patients with hereditary breast cancer

Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients, Genome Medicine